Good day, ladies and gentlemen and welcome to your NewMarket Corporation Conference Call and Webcast to review Third Quarter 2020 Financial Results. All lines have been placed on a listen-only mode. At this time, it is my pleasure to turn the floor over to your host to Brian Paliotti. Sir, the floor is yours.

Thank you, Christy. And thanks everyone for joining us this afternoon. As reminder, some of the statements made during this conference call may be forward-looking, relevant factors that could cause actual results to differ materially from those forward-looking statements are contained in our earnings release. And in our SEC filings, including our most recent form 10-K and our first quarter 10-Q. During this call, we may also discuss the non-GAAP financial measure included in our earnings release. The earnings release, which can be found on our website include the reconciliation of the non-GAAP financial measure to the comparable GAAP financial measure. We filed our 10-Q this morning; it contains significantly more details on the operations and performance of our company. Please take time to review it. I will be referring to the data that was included in last night's release. Net income was $96 million or $8.70 a share compared to net income of $68 million or $6.06 a share for the third quarter of last year. This increased performance includes a one-time $16.5 million gain on the sale of a non-operating real estate asset. This asset was part of our long-term real estate strategy that we've been executing on over the past few decades. This specific Parcel project was kicked-off late last year and closed in the third quarter. Sales for the petroleum additives segment for the third quarter of 2020 were $510 million, compared to sales in the third quarter of 2019 of $551 million. The decrease was due primarily to lower shipments and selling prices. Petroleum additives operating profit for the third quarter of 2020 was $102 million compared to $95 million for the same period last year. The increase was due to lower raw material costs, selling, general and administrative costs, research and development costs partially…